Evaluating the effect of aminexil niosomes on treatment of anderogenetic alopecia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110310006026N8

Enrollment

Registered

2018-05-03

Start date

2018-05-20

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia. Androgenic alopecia

Interventions

Intervention 1: Control group: topical minoxidil 2% solution. Intervention 2: Intervention group: topical aminexil 1% solution. Intervention 3: Intervention group: topical niosomal minoxidil 2%. Inter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men with type 1 and 2 of Norwood classification for hair loss Women with grade 1 and 2 of Ludwig classification of for loss Do not receive any treatment for androgenetic alopecia in the past three months

Exclusion criteria

Exclusion criteria: History of hypersensitivity reactions to the components of the products

Design outcomes

Primary

Measure	Time frame
Hair counting. Timepoint: At baseline and after 6 and 12 weeks. Method of measurement: Dematoscope.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Pardakhty

Kerman University of Medical Sciences

abpardakhty@hotmail.com+98 34 3132 5001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026